ABBVIE, INC. for ABBVIE INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2015 | $1,860,000 | Replaced |
| 1st Quarter - Amendment | Oct 19, 2015 | $1,870,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Discussions and proposals related to the 21st Century Cures initiative; Discussions to clarify or reform the 340B program; Biologics Price Competition and Innovation Act; H.R. 2031, TEST Act H.R. 1101, Viral Hepatitis Testing Act of 2015; S. 2538, Viral Hepatitis Testing Act of 2014; Proposals to improve viral hepatitis screening and testing; Public Law 111-148, The Patient Protection and Affordable Care Act; Implementation of The Prescription Drug User Fee Act (PDUFA);
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN | — |
Copyright/Patent/Trademark CPT
H.R. 3116, MODDERN Cures Act of 2013; H.R. 971, Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015; Proposals/Initiatives related to international intellectual property protection; S. 1720, Patent Transparency and Improvements Act of 2013; H.R. 9, Innovation Act; H.R. 160, Protect Medical Innovation Act of 2015; S. 320, Medical Innovation Act of 2015;
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN | — |
| ADELE R WITENSTEIN | — |
Budget/Appropriations BUD
Labor, Health and Human Services Appropriations; Senate Budget and Veterans' Affairs Appropriations; H.R. 3547, Consolidated Appropriations Act, 2014; FDAs Changes Being Effected Rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN | — |
Taxation/Internal Revenue Code TAX
H.R. 4464, Permanent CFC Look-Through Act of 2014; Administrations Tax Reform and 2015 Budget Proposals; Senate and House Committee Tax Reform Proposals; Proposals to reform domestic and international tax structures (no bills introduced);
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN | — |
Medicare/Medicaid MMM
Policies to enhance patient access to medicines in Medicaid; Policies to enhance patient access to medicines in Medicare; H.R. 909, Andrea Sloan CURE Act; H.R. 2925, Strengthening Medicare Anti-Fraud Measures Act of 2013; S. 31, Medicare Prescription Drug Price Negotiation Act of 2015; S. 740 and H.R. 1588, Medicare Drug Savings Act of 2013;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN | — |
Trade (domestic/foreign) TRD
Trans-Atlantic Trade and Investment Partnership; Trans-Pacific Partnership Agreement; Trade Promotion Authority; U.S.-Turkey Free Trade Agreement; Israeli Trade Issues; WTO Issues; World Intellectual Property Organization Issues;
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.